News & Updates

Varlitinib demonstrate good antitumour activity and an acceptable safety profile in patients with advanced or metastatic solid organ tumours, according to a recent Singapore study.

Surgical resection of recurrent oesophageal squamous cell carcinoma lesions after curative esophagectomy may be beneficial, especially for cases with lower pN stage, lung metastasis, and long recurrence-free interval, according to a study.

New drug applications approved by US FDA as of 16-28 February 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Endoscopic resection (ER) is a safe and effective management approach for oesophageal granular cell tumours (GCT), yielding high rates of procedural success and low long-term mortality and complications, a recent study has found.

Trastuzumab plus endocrine therapy is just as effective as the combination of trastuzumab plus chemotherapy in the first-line treatment of Chinese patients with metastatic breast cancer (MBC) harbouring hormone receptor (HR) or HER2 mutation, with the added advantage of better tolerability, according to the results of the phase III SYSUCC-002 trial.